The nation of Zimbabwe has declined a substantial US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years due to the United States' insistence on confidential information.
The decision became public following a government memo from December was disclosed, which showed President Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesperson later explained that the US was requesting health data for research and profit but refused to share the benefits from any future treatments.
"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for more dialogue to find a deal suitable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Background
This rejection follows a comparable case in neighbouring Kenya, where a court blocked a related health funding agreement after legal challenges were raised about the security of Kenyans' medical information.
After returning to office recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
The agency had managed aid for the American government, but Trump argued its spending was "inefficient" and his administration was seeking government-to-government deals to enhance openness and responsibility.
Based on reports, 16 nations in Africa have so far agreed to similar health pacts, representing over $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment via American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to share its genetic material and health information for a long time, without any equivalent promise of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," he stated.
"Put simply, our country would provide the raw materials for scientific discovery with no assurance that the end products would be accessible to our population if a future pandemic arise."
National Interest and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting structures previously set up through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.
"This system is designed to ensure that when a country provides its data, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the resources to create them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to ongoing discussions with our American counterparts on how subsequent co-operation could be designed in a way that respects the sovereignty and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but suggested that negotiations should continue since a large portion of the nation's Aids initiatives were funded by external financing.
"If technical issues arise, such as those involving information security or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," the group commented.
The halted deal highlights the ongoing tensions between accepting much-needed foreign assistance and protecting local interests in an increasingly data-driven world.